Mostrar el registro sencillo del ítem
Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of an oral probiotic preparation in hidradenitis suppurativa treatment
dc.date.accessioned | 2023-07-03T11:23:29Z | |
dc.date.available | 2023-07-03T11:23:29Z | |
dc.date.issued | 2023-04 | |
dc.identifier.uri | http://hdl.handle.net/10952/6541 | |
dc.description | Randomized, double-blind, placebo-controlled clinical trial, to evaluate an oral probiotic effectiveness administered for 12 weeks on the hidradenitis suppurativa evolution. A total of 60 patients diagnosed with hidradenitis suppurativa will participate in the study, who will be randomized into two treatment groups in a 1:1 ratio (30 patients per group). The intervention groups are differentiated according to the treatment to be received: probiotic or placebo of similar appearance, along with standard therapy according to usual clinical practice. The 12 weeks of treatment are structured into three face-to-face visits: Visit 1 (initial; week 0), Visit 2 (intermediate; week 6) and Visit 3 (final; week 12). | es |
dc.description.abstract | The clinical trial has a randomized, double-blind, placebo-controlled design, which aims to evaluate the effect of an oral probiotic preparation administered for 12 weeks on the evolution of hidradenitis suppurativa | es |
dc.language.iso | en | es |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Hidradenitis suppurativa | es |
dc.subject | Acne inversa | es |
dc.subject | Oral probiotic | es |
dc.subject | Microbiota | es |
dc.subject | Microbiome | es |
dc.title | Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of an oral probiotic preparation in hidradenitis suppurativa treatment | es |
dc.type | other | es |
dc.rights.accessRights | openAccess | es |
dc.description.discipline | Ciencias de la Alimentación | es |
dc.description.discipline | Medicina | es |